IP Verse

Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator - EP3798214

PATENT ANALYSIS

Patent Details

Grant Date
Sep 14, 2022
Company
VERTEX PHARMACEUTICALS INCORPORATED
Oppositions

GENERICS (U.K.) LIMITED

More patents of Vertex Pharmaceuticals Incorporated

EP2464337

EP2914248

EP3925607

Want to monitor this patent?

Feel free to send us a message here and we will get back to you